The Indaptus Goal is Simple: to Cure Disease
With the ability to harness both the body’s innate and adaptive immune responses, we believe we are uniquely positioned to revolutionize the treatment of cancer and certain infectious diseases.
Building on the observation that tumor regression can occur in the setting of bacterial infection, we have developed a proprietary platform that exploits bacteria’s natural ability to activate both innate and adaptive cellular immune pathways. Leveraging our novel insights into the levels and ratios of activating signals needed to safely elicit a broad immune response, we are creating and advancing a pipeline of proprietary, attenuated and killed non-pathogenic gram-negative bacterial candidates designed to be widely accessible, with broad anti-tumor and anti-viral activity.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 3 Columbus Circle,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.indaptusrx.com
- HQ
- New York, New York
Indaptus Therapeutics, Inc. Questions
Indaptus Therapeutics, Inc.'s website is http://www.indaptusrx.com
Indaptus Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/indaptus-therapeutics-inc
Indaptus Therapeutics, Inc. has
10 employees.
View email and phone details for 10
employees at Indaptus Therapeutics, Inc..
Indaptus Therapeutics, Inc.'s industry is
Biotechnology Research
Indaptus Therapeutics, Inc.'s top competitors are
Lexeo Therapeutics,
Bluerock Therapeutics,
Elicio Therapeutics,
Travere Therapeutics,
In8bio,
Springworks Therapeutics,
Stelexis Biosciences, Inc.,
Olatec Therapeutics,
Verve Therapeutics,
Beigene.
Indaptus Therapeutics, Inc.'s categories are Biotechnology Research
Indaptus Therapeutics, Inc.'s founding year is 2021
